The TAB1-p38 alpha complex aggravates myocardial injury and can be targeted by small molecules.
De Nicola, G.F., Bassi, R., Nichols, C., Fernandez-Caggiano, M., Golforoush, P.A., Thapa, D., Anderson, R., Martin, E.D., Verma, S., Kleinjung, J., Laing, A., Hutchinson, J.P., Eaton, P., Clark, J., Marber, M.S.(2018) JCI Insight 3
- PubMed: 30135318 
- DOI: https://doi.org/10.1172/jci.insight.121144
- Primary Citation of Related Structures:  
5NZZ - PubMed Abstract: 
Inhibiting MAPK14 (p38α) diminishes cardiac damage in myocardial ischemia. During myocardial ischemia, p38α interacts with TAB1, a scaffold protein, which promotes p38α autoactivation; active p38α (pp38α) then transphosphorylates TAB1. Previously, we solved the X-ray structure of the p38α-TAB1 (residues 384-412) complex ...